XEN 45 Glaucoma Treatment System
- Risk class
- Class III
- CND nomenclatures code
- Q0208
- Trade name
- XEN 45 GLAUCOMA TREATMENT SYSTEM
- Implantable
- Yes
- Reusable
- No
- Measuring function
- No
- Primary DI
- 10888628032439
- Basic UDI
- B-10888628032439
- Version date
- March 06, 2025
- Manufacturer last update
- November 21, 2024
- Active status
- No
- Manufacturer name
- Allergan Sales, LLC
- Country
- United States
- Country type
- NON_EU
- Address
- 2525 Dupont Drive Irvine, California
- customerservice@abbvie.com
- SRN
- IE-AR-000000650
- Country
- Ireland
- Address
- Clonshaugh Business & Technology Park Dublin 17
- EU_AR@abbvie.com
- Telephone
- +353 1 435 7700
- Competent authority
- Health Products Regulatory Authority, Medical Devices Department
- Applicable legislation
- MDD (Directive 93/42/EEC on Medical Devices)
- Placed on the market
- Ireland
- Market available
- Italy:2013-08-06~None, Liechtenstein:2013-08-06~None, Lithuania:2013-08-06~None, Luxembourg:2013-08-06~None, Latvia:2013-08-06~None, Malta:2013-08-06~None, Netherlands:2013-08-06~None, Norway:2013-08-06~None, Poland:2013-08-06~None, Portugal:2013-08-06~None, Romania:2013-08-06~None, Sweden:2013-08-06~None, Slovenia:2013-08-06~None, Slovakia:2013-08-06~None, Türkiye:2013-08-06~None, United Kingdom (Northern Ireland only):2013-08-06~None, Iceland:2013-08-06~None, Ireland:2013-08-06~None, Hungary:2013-08-06~None, Croatia:2013-08-06~None, Greece:2013-08-06~None, France:2013-08-06~None, Finland:2013-08-06~None, Spain:2013-08-06~None, Estonia:2013-08-06~None, Denmark:2013-08-06~None, Germany:2013-08-06~None, Czechia:2013-08-06~None, Cyprus:2013-08-06~None, Bulgaria:2013-08-06~None, Belgium:2013-08-06~None, Austria:2013-08-06~None
- Human tissues
- No
- Animal tissues
- Yes
GLAUCOMA DRAINAGES AND KITS
Access comprehensive regulatory information for XEN 45 Glaucoma Treatment System in the European Union medical device market through Pure Global AI's free database. This Class III device is registered with EU EUDAMED under Primary DI 10888628032439 and manufactured by Allergan Sales, LLC in United States.
This page provides complete registration details including trade name (XEN 45 GLAUCOMA TREATMENT SYSTEM), manufacturer information, authorized representative details, competent authority (Health Products Regulatory Authority, Medical Devices Department), and regulatory compliance data from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry, helping global MedTech companies navigate EU MDR regulations efficiently.